Acusphere gets financing for development

AuntMinnie.com staff writers
Apr 20, 2003

Ultrasound contrast developer Acusphere has completed a $20 million private financing round. The Watertown, MA-based company received over $19 million in funding, with additional funding commitments scheduled to close in June.

Acusphere said it would use the proceeds to fund continued advancement of its products, particularly its AI-700 ultrasound contrast agent, which recently entered phase III clinical trials. AI-700 is designed for use in detecting coronary artery disease in patients with ischemic heart disease.

By AuntMinnie.com staff writers
April 21, 2003

Related Reading

Acusphere launches phase III trials, February 26, 2003

Acusphere raises $15 million, July 24, 2002

Acusphere US contrast agent research presented at ASE, July 19, 2001

Copyright © 2003 AuntMinnie.com

Latest in Ultrasound
Liver Anatomy Social
Clinicians need education regarding HCC surveillance resources
May 14, 2024
A case presented at the ARRS annual meeting shows the results of successful microwave ablation (MWA) treatment for a 39-year-old female with metastatic fibrosarcoma of the right axillary sinus.
ARRS: MWA safe, effective method to treat bone metastases
May 10, 2024
Ultrasound Scanner Ultraviolet 400
Deep-learning algorithm improves liver fibrosis diagnosis
April 23, 2024
Screenshot (1142)
POCUS used widely in lung ultrasound applications
April 17, 2024
Related Stories
Cc99 Ff Dot
Ultrasound
Strict attention to detail enhances sensitivity of breast US
2002 12 16 13 40 13 706
Ultrasound
Ultrasound of the pancreas: what normal looks like
2002 11 15 18 08 53 706
Ultrasound
New ultrasound products highlight modality’s expansion
2002 09 30 15 13 07 706
Ultrasound
Study questions value of targeted US for breast pain
More in Ultrasound
Clinicians need education regarding HCC surveillance resources
By Amerigo Allegretto
Clinicians need education to understand hepatocellular carcinoma (HCC) tracking and surveillance resources.
May 14, 2024
Liver Anatomy Social
ARRS: MWA safe, effective method to treat bone metastases
By Amerigo Allegretto
Ultrasound-guided microwave ablation (MWA) is a safe, effective method for treating bone metastases.
May 10, 2024
A case presented at the ARRS annual meeting shows the results of successful microwave ablation (MWA) treatment for a 39-year-old female with metastatic fibrosarcoma of the right axillary sinus.
Deep-learning algorithm improves liver fibrosis diagnosis
By Amerigo Allegretto
An algorithm combining the Fibrosis-4 Index and an ultrasound deep-learning model could improve diagnostic accuracy for advanced liver fibrosis.
April 23, 2024
Ultrasound Scanner Ultraviolet 400
POCUS used widely in lung ultrasound applications
By Amerigo Allegretto
Some of the top domains for users of point-of-care ultrasound (POCUS) incorporate the technology for lung ultrasound applications.
April 17, 2024
Screenshot (1142)
UltraCon: Expert talks ultrasound's role in imaging dense breasts
By Amerigo Allegretto
Kibo Nam, PhD, from Thomas Jefferson University spoke with AuntMinnie.com about the current state of ultrasound in imaging dense breasts.
April 12, 2024
Img 2490
Negative axillary ultrasound can lead to breast biopsy omission
By Amerigo Allegretto
Many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.
April 12, 2024
Andreas Giannakou, MD, from Brigham & Women’s Hospital and Harvard Medical School presents research highlighting how many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.
UltraCon: Work-related MSK disorders tied to sonographer burnout
By Amerigo Allegretto
Work-related musculoskeletal (MSK) disorders are tied to work-related burnout among sonographers, according to research highlighted April 10 at UltraCon.
April 11, 2024
Jennifer Bagley from the University of Oklahoma Health Sciences Center presents results at UltraCon suggesting that work-related musculoskeletal disorders are tied to burnout among sonographers.
CEUS adds to locoregional therapy for liver disease
By Amerigo Allegretto
Contrast-enhanced ultrasound (CEUS) can improve locoregional therapy for treating metastatic disease of the liver.
April 11, 2024
Corinne Wessner from Thomas Jefferson University discusses early study results at UltraCon showing the potential of ultrasound-triggered microbubble destruction in treating liver disease.
UltraCon: Harmonic motion imaging tracks breast tumor response to chemo
By Amerigo Allegretto
Harmonic motion imaging can track mechanical property changes of breast tumors in response to neoadjuvant chemotherapy.
April 10, 2024
Yangpei Liu from Columbia University in Ney York City discussed findings at UltraCon suggesting that harmonic motion imaging could be a viable predictor of early treatment response.
UltraCon: Former Medtronic CEO talks ultrasound's future with AuntMinnie.com
By Amerigo Allegretto
Former Medtronic Chairman and CEO Omar Ishrak, PhD, spoke with AuntMinnie.com at UltraCon on the future of ultrasound and market creation.
April 10, 2024
Img 2502
UltraCon: Machine learning predicts sonographer burnout
By Amerigo Allegretto
Machine-learning approaches can predict burnout among sonographers, though established burnout indices may be enough, according to research presented April 9 at UltraCon.
April 9, 2024
Jennifer Bagley from the University of Oklahoma presents findings at UltraCon on the performance of two machine learning approaches in predicting burnout among sonographers.
UltraCon: Ultrasound empowers patients with prosthetic limbs
By Amerigo Allegretto
Gil Weinberg, PhD, a founding director of Georgia Tech's Center for Music Technology, spoke with AuntMinnie.com on ultrasound's use in prosthetics.
April 9, 2024
Img 2547
Page 1 of 509
Next Page